L-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease

Behavioural Brain Research

Volumn 230, Issue 1, 2012, Pages 116-124

  Kwak, Youngbin ^a,d   Müller, Martijn L T M ^a   Bohnen, Nicolaas I ^a   Dayalu, Praveen ^a   Seidler, Rachael D ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

Dopamine; FMRI; Motor sequence learning; Parkinson's disease

Indexed keywords

CARBIDOPA; LEVODOPA; PLACEBO;

ADULT; AGED; ARTICLE; BOLD SIGNAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; FEMALE; HUMAN; LEARNING; MALE; MENTAL PERFORMANCE; MOTOR ACTIVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; BASAL GANGLIA; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PARKINSON DISEASE; REACTION TIME; SERIAL LEARNING; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 84863419791     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.02.006     Document Type: Article

References (72)

1. Kwak Y., Muller M.L., Bohnen N.I., Dayalu P., Seidler R.D. Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's disease. J Neurophysiol 2010, 103:942-949.
2. Balleine B.W., O'Doherty J.P. Human and rodent homologies in action control: corticostriatal determinants of goal-directed and habitual action. Neuropsychopharmacology 2010, 35:48-69.
3. MacDonald P.A., MacDonald A.A., Seergobin K.N., Tamjeedi R., Ganjavi H., Provost J.S., et al. The effect of dopamine therapy on ventral and dorsal striatum-mediated cognition in Parkinson's disease: support from functional MRI. Brain 2011, 134:1447-1463.
4. Macdonald P.A., Monchi O. Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function. Parkinsons Dis 2011, 2011:572743.
5. Seo M., Beigi M., Jahanshahi M., Averbeck B.B. Effects of dopamine medication on sequence learning with stochastic feedback in Parkinson's disease. Front Syst Neurosci 2010, 2010.
6. Tremblay P.L., Bedard M.A., Langlois D., Blanchet P.J., Lemay M., Parent M. Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease. Exp Brain Res 2010, 205:375-385.
7. Bapi R.S., Miyapuram K.P., Graydon F.X., Doya K. fMRI investigation of cortical and subcortical networks in the learning of abstract and effector-specific representations of motor sequences. Neuroimage 2006, 32:714-727.
8. Doyon J., Penhune V., Ungerleider L.G. Distinct contribution of the cortico-striatal and cortico-cerebellar systems to motor skill learning. Neuropsychologia 2003, 41:252-262.
9. Duff E., Xiong J., Wang B., Cunnington R., Fox P., Egan G. Complex spatio-temporal dynamics of fMRI BOLD: A study of motor learning. Neuroimage 2007, 34:156-168.
10. Lehericy S., Benali H., Van de Moortele P.F., Pelegrini-Issac M., Waechter T., Ugurbil K., et al. Distinct basal ganglia territories are engaged in early and advanced motor sequence learning. Proc Natl Acad Sci USA 2005, 102:12566-12571.
11. van Mier H.I., Perlmutter J.S., Petersen S.E. Functional changes in brain activity during acquisition and practice of movement sequences. Motor Control 2004, 8:500-520.
12. Doyon J., Benali H. Reorganization and plasticity in the adult brain during learning of motor skills. Curr Opin Neurobiol 2005, 15:161-167.
13. Berns G.S., Cohen J.D., Mintun M.A. Brain regions responsive to novelty in the absence of awareness. Science 1997, 276:1272-1275.
14. Tamas Kincses Z., Johansen-Berg H., Tomassini V., Bosnell R., Matthews P.M., Beckmann C.F. Model-free characterization of brain functional networks for motor sequence learning using fMRI. Neuroimage 2008, 39:1950-1958.
15. Hikosaka O., Nakamura K., Sakai K., Nakahara H. Central mechanisms of motor skill learning. Curr Opin Neurobiol 2002, 12:217-222.
16. Doyon J. Motor sequence learning and movement disorders. Curr Opin Neurol 2008, 21:478-483.
17. Cools R., Clark L., Owen A.M., Robbins T.W. Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci 2002, 22:4563-4567.
18. Cools R., Altamirano L., D'Esposito M. Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia 2006, 44:1663-1673.
19. Cools R., Barker R.A., Sahakian B.J., Robbins T.W. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cerebral Cortex 2001, 11:1136-1143.
20. Catalan M.J., Ishii K., Honda M., Samii A., Hallett M. A PET study of sequential finger movements of varying length in patients with Parkinson's disease. Brain 1999, 122:483-495.
21. Mallol R., Barros-Loscertales A., Lopez M., Belloch V., Parcet M.A., Avila C. Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements. Brain Res 2007, 1147:265-271.
22. Samuel M., CeballosBaumann A.O., Blin J., Uema T., Boecker H., Passingham R.E., et al. Evidence for lateral premotor and parietal overactivity in Parkinson's disease during sequential and bimanual movements - A PET study. Brain 1997, 120:963-976.
23. Carbon M., Eidelberg D. Functional imaging of sequence learning in Parkinson's disease. J Neurol Sci 2006, 248:72-77.
24. Carbon M., Ghilardi M.F., Feigin A., Fukuda M., Silvestri G., Mentis M.J., et al. Learning networks in health and Parkinson's disease: reproducibility and treatment effects. Hum Brain Mapp 2003, 19:197-211.
25. Nakamura T., Ghilardi M.F., Mentis M., Dhawan V., Fukuda M., Hacking A., et al. Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease. Hum Brain Mapp 2001, 12:42-60.
26. Argyelan M., Carbon M., Ghilardi M.F., Feigin A., Mattis P., Tang C., et al. Dopaminergic suppression of brain deactivation responses during sequence learning. J Neurosci 2008, 28:10687-10695.
27. Cools R., Lewis S.J.G., Clark L., Barker R.A., Robbins T.W. l-DOPA disrupts activity in the nucleus accumbens during reversal learning in Parkinson's disease. Neuropsychopharmacology 2007, 32:180-189.
28. Desmurget M., Turner R.S. Motor sequences and the basal ganglia: kinematics, not habits. J Neurosci 2010, 30:7685-7690.
29. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
30. Fahn S., Elton R. Committee. MotUD. The Unified Parkinson's Disease Rating Scale. Recent developments in Parkinson's disease 1987, 293-304. Macmillan Health Care Information, Florham Park, NJ. S. Fahn, C.D. Marsden, D.B. Calne, M. Goldstein (Eds.).
31. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
32. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005, 53:695-699.
33. Oppenheim A., Schafer R., Buck J. Discrete-time signal processing 1999, Prentice Hall, Upper Saddle River, NJ.
34. Forman S.D., Cohen J.D., Fitzgerald M., Eddy W.F., Mintun M.A., Noll D.C. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med 1995, 33:636-647.
35. Knutson K.M., Wood J.N., Grafman J. Brain activation in processing temporal sequence: an fMRI study. Neuroimage 2004, 23:1299-1307.
36. Knutson K.M., Wood J.N., Spampinato M.V., Grafman J. Politics on the brain: an FMRI investigation. Soc Neurosci 2006, 1:25-40.
37. Konishi S., Nakajima K., Uchida I., Kikyo H., Kameyama M., Miyashita Y. Common inhibitory mechanism in human inferior prefrontal cortex revealed by event-related functional MRI. Brain 1999, 122:981-991.
38. Konishi S., Nakajima K., Uchida I., Sekihara K., Miyashita Y. No-go dominant brain activity in human inferior prefrontal cortex revealed by functional magnetic resonance imaging. Eur J Neurosci 1998, 10:1209-1213.
39. Monk C.S., Peltier S.J., Wiggins J.L., Weng S.J., Carrasco M., Risi S., et al. Abnormalities of intrinsic functional connectivity in autism spectrum disorders. Neuroimage 2009, 47:764-772.
40. Poldrack R.A., Wagner A.D., Prull M.W., Desmond J.E., Glover G.H., Gabrieli J.D.E. Functional specialization for semantic and phonological processing in the left inferior prefrontal cortex. Neuroimage 1999, 10:15-35.
41. Wagner A.D., Pare-Blagoev E.J., Clark J., Poldrack R.A. Recovering meaning: left prefrontal cortex guides controlled semantic retrieval. Neuron 2001, 31:329-338.
42. Bo J., Peltier S.J., Noll D.C., Seidler R.D. Symbolic representations in motor sequence learning. Neuroimage 2011, 54:417-426.
43. Garraux G., Peigneux P., Carson R.E., Hallett M. Task-related interaction between basal ganglia and cortical dopamine release. J Neurosci 2007, 27:14434-14441.
44. Peigneux P., Maquet P., Meulemans T., Destrebecqz A., Laureys S., Degueldre C., et al. Striatum forever, despite sequence learning variability: a random effect analysis of PET data. Hum Brain Mapp 2000, 10:179-194.
45. Rauch S.L., Whalen P.J., Savage C.R., Curran T., Kendrick A., Brown H.D., et al. Striatal recruitment during an implicit sequence learning task as measured by functional magnetic resonance imaging. Hum Brain Mapp 1997, 5:124-132.
46. Reiss J.P., Campbell D.W., Leslie W.D., Paulus M.P., Stroman P.W., Polimeni J.O., et al. The role of the striatum in implicit learning: a functional magnetic resonance imaging study. Neuroreport 2005, 16:1291-1295.
47. Rieckmann A., Fischer H., Backman L. Activation in striatum and medial temporal lobe during sequence learning in younger and older adults: relations to performance. Neuroimage 2010, 50:1303-1312.
48. Bollen K.A., Jackman R. Regression diagnostics: an expository treatment of outliers and influential cases. Modern methods of data analysis 1990, 257-291. Sage, Newbury Park. J. Fox, J.S. Long (Eds.).
49. Rhodes B.J., Bullock D., Verwey W.B., Averbeck B.B., Page M.P. Learning and production of movement sequences: behavioral, neurophysiological, and modeling perspectives. Hum Mov Sci 2004, 23:699-746.
50. Ashe J., Lungu O.V., Basford A.T., Lu X. Cortical control of motor sequences. Curr Opin Neurobiol 2006, 16:213-221.
51. Serrien D.J., Ivry R.B., Swinnen S.P. Dynamics of hemispheric specialization and integration in the context of motor control. Nat Rev Neurosci 2006, 7:160-166.
52. Jubault T., Monetta L., Strafella A.P., Lafontaine A.L., Monchi O. l-DOPA medication in Parkinson's disease restores activity in the motor cortico-striatal loop but does not modify the cognitive network. PLoS One 2009, 4:e6154.
53. Ferdinand N.K., Mecklinger A., Kray J. Error and deviance processing in implicit and explicit sequence learning. J Cogn Neurosci 2008, 20:629-642.
54. Russeler J., Kuhlicke D., Munte T.F. Human error monitoring during implicit and explicit learning of a sensorimotor sequence. Neurosci Res 2003, 47:233-240.
55. Seidler R.D., Tuite P., Ashe J. Selective impairments in implicit learning in Parkinson's disease. Brain Res 2007, 1137:104-110.
56. Glascher J., Daw N., Dayan P., O'Doherty J.P. States versus rewards: dissociable neural prediction error signals underlying model-based and model-free reinforcement learning. Neuron 2010, 66:585-595.
57. Haruno M., Kawato M. Different neural correlates of reward expectation and reward expectation error in the putamen and caudate nucleus during stimulus-action-reward association learning. J Neurophysiol 2006, 95:948-959.
58. McClure S.M., Berns G.S., Montague P.R. Temporal prediction errors in a passive learning task activate human striatum. Neuron 2003, 38:339-346.
59. O'Doherty J.P., Dayan P., Friston K., Critchley H., Dolan R.J. Temporal difference models and reward-related learning in the human brain. Neuron 2003, 38:329-337.
60. Schonberg T., Daw N.D., Joel D., O'Doherty J.P. Reinforcement learning signals in the human striatum distinguish learners from nonlearners during reward-based decision making. J Neurosci 2007, 27:12860-12867.
61. Frank M.J., Seeberger L.C., O'Reilly R.C. By carrot or by stick: cognitive reinforcement learning in Parkinsonism. Science 2004, 306:1940-1943.
62. Rutledge R.B., Lazzaro S.C., Lau B., Myers C.E., Gluck M.A., Glimcher P.W. Dopaminergic drugs modulate learning rates and preservation in Parkinson's patients in a dynamic foraging task. J Neurosci 2009, 29:15104-15114.
63. Jancke L., Specht K., Mirzazade S., Loose R., Himmelbach M., Lutz K., et al. A parametric analysis of the 'rate effect' in the sensorimotor cortex: a functional magnetic resonance imaging analysis in human subjects. Neurosci Lett 1998, 252:37-40.
64. van Mier H., Tempel L.W., Perlmutter J.S., Raichle M.E., Petersen S.E. Changes in brain activity during motor learning measured with PET: effects of hand of performance and practice. J Neurophysiol 1998, 80:2177-2199.
65. Cools R., Frank M.J., Gibbs S.E., Miyakawa A., Jagust W., D'Esposito M. Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci 2009, 29:1538-1543.
66. Cools R., Sheridan M., Jacobs E., D'Esposito M. Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory. J Neurosci 2007, 27:5506-5514.
67. Frank M.J., Fossella J.A. Neurogenetics and pharmacology of learning, motivation, and cognition. Neuropsychopharmacology 2011, 36:133-152.
68. Frank M.J., O'Reilly R.C. A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci 2006, 120:497-517.
69. Kimberg D.Y., D'Esposito M., Farah M.J. Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 1997, 8:3581-3585.
70. Roesch-Ely D., Scheffel H., Weiland S., Schwaninger M., Hundemer H.P., Kolter T., et al. Differential dopaminergic modulation of executive control in healthy subjects. Psychopharmacology (Berl) 2005, 178:420-430.
71. Cools R. Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006, 30:1-23.
72. Dumitriu A., Popescu B.O. Placebo effects in neurological diseases. J Med Life 2010, 3:114-121.